The incidence of (POD) was 10.9% in elderly patients receiving compared to 30.4% in the control group.
Postoperative delirium occurred in 20.7% of the overall study population.
Intranasal insulin administration was associated with a significant reduction in POD incidence within five days post-surgery.
On postoperative day 3, the insulin group showed a reduced POD incidence of 2.2%, compared to 19.6% in the control group.
Serum levels of interleukin-6 and C-reactive protein were significantly lower in the insulin group compared to controls on postoperative day 1.
Both groups experienced significant increases in interleukin-6 and C-reactive protein levels from baseline to postoperative day 1.
Simplified
OBJECTIVE: (POD) frequently occurs among elderly patients following surgery, yet effective preventive measures remain insufficiently established. This study aimed to investigate whether perioperative (INI) administration could reduce the incidence of POD and modulate inflammatory marker levels in elderly patients undergoing hip fracture surgery under general anesthesia (GA).
METHODS: From June to December 2024, a total of 96 elderly patients scheduled for hip fracture surgery with GA were enrolled and randomly assigned to two groups (48 per group). Patients in the insulin group received INI (20 units in 0.5 mL) twice daily, beginning two days preoperatively and continuing for five days. Patients in the control group received an equivalent volume of saline (0.5 mL) with the same dosing regimen. The primary outcome was POD incidence within five postoperative days, evaluated using the 3D-CAM-CN assessment tool. Secondary outcomes included serum levels of interleukin-6 (IL-6) and C-reactive protein (CRP), measured at baseline (T0; before intervention) and postoperative day 1 (T1) using immunofluorescence quantitative assays.
RESULTS: Ninety-two patients completed the study, with an overall POD incidence rate of 20.7%. Patients treated with INI showed a significantly lower incidence of POD within the 5-day postoperative period (10.9% vs. 30.4%, P = 0.020). On postoperative day 3 (T2), the incidence of POD was notably reduced in the insulin group (2.2% vs. 19.6%, P = 0.007). No significant differences in POD incidence were observed on postoperative days 1 (T1) or 5 (T3). Serum IL-6 and CRP levels at T1 were lower in the insulin group compared to controls (P < 0.001), although both groups experienced significant elevations in these markers at T1 compared to baseline (T0) (P < 0.001). No adverse events related to interventions occurred during the study.
CONCLUSION: Perioperative INI administration reduced the incidence of POD and decreased postoperative inflammatory markers (IL-6 and CRP) in elderly patients undergoing hip fracture surgery with GA.
TRIAL REGISTRATION: This study was registered in the Chinese Clinical Trial Register (registration no. ChiCTR2400085627, registration date on 14/6/2024).
Key numbers
10.9%
Decrease in Incidence
incidence in the insulin group within five postoperative days.
2.2%
Incidence at Day 3
incidence in the insulin group on postoperative day 3.
20.7%
Overall Incidence
Total incidence across both groups during the study.
Full Text
We can’t show the full text here under this license.
Declarations. Ethics approval and consent to participate: This study was approved by the Ethics Committee of Fuyang People’s Hospital branch (Medical Ethics Review [2023]95) and was registered with the Chinese Clinical Trial Registry (registration no. ChiCTR2400085627). Prior written informed consent was obtained from all participants. All methods were performed in accordance with the relevant guidelines and regulations of the Helsinki Declaration. Consent for publication: Not applicable. Competing interests: The authors declare no competing interests.
